Smoking, chronic obstructive pulmonary disease and lung cancer;Tabakrauchen, chronisch obstruktive lungenerkrankung und lungenkarzinom

Pneumologie

Volumn 61, Issue 9, 2007, Pages 590-595

  Andreas, Stefan ^a,c   Herth, F J F ^b   Rittmeyer, A ^a   Kyriss, T ^a   Raupach, T ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c Lungenfachklinik Immenhausen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; HUMAN; LUNG CANCER; MORTALITY; OXIDATIVE STRESS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SMOKING CESSATION; TUMOR SUPPRESSOR GENE; COMORBIDITY; GERMANY; INCIDENCE; LUNG TUMOR; METHODOLOGY; SMOKING; STATISTICS;

COMORBIDITY; GERMANY; HUMANS; INCIDENCE; LUNG NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TOBACCO USE CESSATION;

EID: 34548846685     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-980121     Document Type: Review

References (71)

1. Consortium A. Tobacco or health in the European Union. European Commission 2004; ISBN 92-894-8219-2: p. 1-295
2. Godtfredsen NS, Vestbo J, Osler M et al. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax 2002; 57: 967-972
3. Meyer PA, Mannino DM, Redd SC et al. Characteristics of adults dying with COPD. Chest 2002; 122: 2003-2008
4. Calverley PM, Anderson JA, Celli B et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789
5. Shahab L, Jarvis MJ, Britton J et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006; 61:1043-1047
6. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care 2003; 48: 1204-1213: discussion: 1213-1215
7. Lundback B, Lindberg A, Lindstrom M et al. Not 15 but 50% of smokers develop COPD? - Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97: 115-122
8. de Marco R, Accordini S, Cerveri I et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages.Thorax 2004; 59: 120-125
9. Ben-Zaken Cohen S, Pare PD, Man SFP et al. The Growing Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer in Women: Examining Sex Differences in Cigarette Smoke Metabolism. 10.1164/rccm.200611-1655PP. Am J Respir Crit Care Med 2007; 176: 113-120
10. Society ER. Lifting the smoke screen - 10 reasons for a smoke free Europe. Brussels: European Respiratory Society: B-1000, 2006: p. 28ff
11. Jaakkola MS, Jaakkola JJ. Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention. Eur Respir J 2006; 28: 397-408
12. Kerstjens HA, Rijcken B, Scheuten JP et al. Decline of FEV, by age and smoking status: facts, figures, and fallacies. Thorax 1997; 52: 820-827
13. Gold DR, Wang X, Wypij D et al. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med 1996; 335: 931-937
14. Sherrill DL, Lebowitz MD, Knudson RJ et al. Smoking and symptom effects on the curves of lung function growth and decline. Am Rev Respir Dis 1991; 144: 17-22
15. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645-1648
16. Tashkin DP, Detels R, Simmons M et al. The UCLA population studies of chronic obstructive respiratory disease: XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second. Am J Respir Crit Care Med 1994; 149: 1209-1217
17. Kemeny DM, Vyas B. Vukmanovic-Stejic M et al. CD8(+) T cell subsets and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: S33-37
18. 1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51: 267-271
19. Hautamaki RD, Kobayashi DK, Senior RM et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277: 2002-2004
20. Marui N, Offermann MK, Swerlick R et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92: 1866-1874
21. Shapiro SD. The pathogenesis of emphysema: the elastase:antielastase hypothesis 30 years later. Proc Assoc Am Physicians 1995; 107: 346-352
22. 1. The Lung Health Study. Jama 1994; 272: 1497-1505
23. Molfino NA. Genetics of COPD. Chest 2004; 125: 1929-1940
24. He JQ, Ruan J, Connett JE et al. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 2002; 166: 323-328
25. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364: 709-721
26. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22: 672-688
27. Wouters EF. Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax 2002; 57: 1067-1070
28. Reid MB. COPD as a muscle disease. Am J Respir Crit Care Med 2001; 164: 1101-1102
29. Andreas S, Anker SD, Scanlon PD et al. Neurohumoral activation as a link to systemic manifestation of chronic lung disease. Chest 2005; 128: 3618-3624
30. Narkiewicz K, Borne PJ van de, Hausberg M et al. Cigarette smoking increases sympathetic outflow in humans. Circulation 1998; 98: 528-534
31. Scanlon PD, Connett JE, Waller LA et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161: 381-390
32. Willemse BW, Postma DS, Timens W et al. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004; 23: 464-476
33. Anthonisen NR, Skeans MA, Wise RA et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 233-239
34. Raupach T, Nowak D, Hering T et al. Smoking and pulmonary diseases, positive effects of smoking cessation. Pneumologie 2007; 61: 11-14
35. Meer RM van der, Wagena EJ, Ostelo RWJG et al. Smoking cessation for chronic obstructive pulmonary disease (Cochrane Review). In The Cochrane Library. Ltd.: Chichester, UK: John Wiley & Sons, 2004
36. Tashkin D, Kanner R, Bailey W et al. Smoking cessation inpatients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 2001; 357: 1571-1575
37. Wagena EJ, Zeegers MP, Schayck CP van et al. Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease. Drug Saf 2003; 26: 381-403
38. 1): results from the Lung Health Study. Eur Respir J 2005; 25: 1011-1017
39. Lacasse Y, LaForge J, Maltais F. Got a match? Home oxygen therapy in current smokers. Thorax 2006; 61: 374-375
40. Weißbuch Lunge 2005, ed. N. Konietzko. Stuttgart: Georg Thieme Verlag, 2005
41. Parrott S, Godfrey C, Raw M et al. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority. Thorax 1998; 53 Suppl 5 Pt 2: S1-38
42. Peto R, Darby S, Deo H et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. Bmj 2000; 321: 323-329
43. The Health Consequences of Smoking: A Report of the Surgeon General. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. Atlanta, GA: Office on Smoking and Health, 2004
44. Zhou W, Heist RS, Liu G et al. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients. Lung Cancer 2006; 53: 375-380
45. Tsao AS, Liu D, Lee JJ et al. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer 2006; 106: 2428-2436
46. Thomas L, Doyle LA, Edelman MJ. Lung cancer in women: emerging differences in epidemiology, biology, and therapy. Chest 2005; 128: 370-381
47. Keil U, Becher H, Heidrich J et al. Passivrauchbedingte Morbidität und Mortalität in Deutschland. In: Passivrauchen - ein unterschätztes Gesundheitsrisiko. Heidelberg: Deutsches Krebsforschungszentrum, 2005
48. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. Bmj 1997; 315: 980-988
49. Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 1963; 30: 289-312
50. Sanderson Cox L, Patten CA, Ebbert JO et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. J Clin Oncol 2002; 20: 3461-3469
51. Dresler CM. Is it more important to quit smoking than which chemotherapy is used? Lung Cancer 2003; 39: 119-124
52. Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev2005; 14: 2287-2293
53. Vaporciyan AA, Merriman KW, Ece F et al. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Ann Thorac Surg 2002; 73: 420-425; discussion: 425-426
54. Moller AM, Pedersen T, Villebro N et al. A study of the impact of long-term tobacco smoking on postoperative intensive care admission. Anaesthesia 2003; 58: 55-59
55. Moller AM, Villebro N, Pedersen T et al. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002; 359: 114-117
56. Baser S, Shannon VR, Eapen GA et al. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest 2006; 130: 1784-1790
57. Tammemagi CM, Neslund-Dudas C, Simoff M et al. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol 2004; 57: 597-609
58. Toh CK, Wong EH, Lim WT et al. The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis. Chest 2004; 126: 1750-1756
59. Hamilton M, Wolf JL, Rusk J, Beard SE et al. Effects of smoking on the pharmacokinetics of erlotinib. Clin Cancer Res 2006; 12: 2166-2171
60. Buccheri G, Ferrigno D. Importance of weight loss definition in the prognostic evaluation of non-small-cell lung cancer. Lung Cancer 2001; 34: 433-440
61. Issell BF, Valdivieso M, Hersh EM et al. Combination chemoimmunotherapy for extensive non-oat cell lung cancer. Cancer Treat Rep 1978; 62: 1059-1063
62. Matthews NE, Adams MA, Maxwell IR et al. Nitric oxide-mediated regulation of chemosensitivity in cancer cells. J Natl Cancer Inst 2001; 93: 1879-1885
63. Dasgupta P, Kinkade R, Joshi B et al. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA 2006; 103: 6332-6337
64. Fox JL, Rosenzweig KE, Ostroff JS. The effect of smoking status on survival following radiation therapy for non-small cell lung cancer. Lung Cancer 2004; 44: 287-293
65. Videtic GM, Stitt LW, Dar AR et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 2003; 21: 1544-1549
66. Sarihan S, Ercan I, Saran A et al. Evaluation of infections in non-small cell lung cancer patients treated with radiotherapy. Cancer Detect Prev 2005; 29: 181-188
67. Monson JM, Stark P, Reilly JJ et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 1998; 82: 842-850
68. Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 2005; 63: 5-24
69. Tucker MA, Murray N, Shaw EG et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst 1997; 89: 1782-1788
70. Richardson GE, Tucker MA, Venzon DJ et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993; 119: 383-390
71. Ruff LK, Volmer T, Nowak D et al. The economic impact of smoking in Germany. Eur Respir J 2000; 16: 385-390